Tomić Nives Gojo, Marusić Srećko, Bozikov Velimir, Kusec Rajko, Bacić-Vrca Vesna, Tadić Mario
University of Zagreb, University Hospital Dubrava, Department of Clinical Pharmacology, Zagreb, Croatia.
Coll Antropol. 2013 Sep;37(3):789-93.
Methylenetetrahydrofolate reductase (MTHFR) polymorphism has been shown to be associated with the development of diabetic nephropathy in many ethnic groups. In this study, we examined the correlation between MTHFR C677T polymorphism and microalbuminuria in patients with diabetes mellitus type 2 in Croatian patients. 85 patients with diabetes mellitus type 2 were recruited. Patients were classified into two groups--with and without diabetic nephropathy according to urinary albumin excretion rate in urine collected during 24 hours. The C677T genotype was determined by real-time PCR analysis. The genotype frequencies were CC 36.5%, CT 42.3% and TT 21.2% in diabetic patients without nephropathy versus CC 39.4%, CT 45.4% and TT 15.2% in those with nephropathy. There was no statistically significant difference in allele distribution between patients with nephropathy and those without (p = 0.788). Our study did not show a correlation between mutations in the MTHFR gene and diabetic nephropathy in Croatian patients. Diabetic nephropathy is influenced by multiple risk factors which can modify the importance of MTHFR polymorphism in its development.
亚甲基四氢叶酸还原酶(MTHFR)基因多态性已被证明在许多种族中与糖尿病肾病的发生有关。在本研究中,我们检测了克罗地亚2型糖尿病患者中MTHFR C677T基因多态性与微量白蛋白尿之间的相关性。招募了85例2型糖尿病患者。根据24小时尿液收集的尿白蛋白排泄率,将患者分为两组——有糖尿病肾病组和无糖尿病肾病组。通过实时聚合酶链反应分析确定C677T基因型。无肾病的糖尿病患者中CC基因型频率为36.5%,CT基因型频率为42.3%,TT基因型频率为21.2%;而有肾病的患者中CC基因型频率为39.4%,CT基因型频率为45.4%,TT基因型频率为15.2%。肾病患者和无肾病患者之间的等位基因分布没有统计学显著差异(p = 0.788)。我们的研究未显示克罗地亚患者中MTHFR基因突变与糖尿病肾病之间存在相关性。糖尿病肾病受多种风险因素影响,这些因素可能改变MTHFR基因多态性在其发生发展中的重要性。